• LOGIN
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publication
  • Projects
  • Funding
  • Research Data
  • Organizations
  • Researchers
  • LOGIN
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Systematic identification of novel cancer genes through analysis of deep shRNA perturbation screens.
 

Systematic identification of novel cancer genes through analysis of deep shRNA perturbation screens.

Options
  • Details
BORIS DOI
10.48350/163430
Date of Publication
September 7, 2021
Publication Type
Article
Division/Institute

Department for BioMed...

Author
Montazeri, Hesam
Coto-Llerena, Mairene
Bianco, Gaia
Zangene, Ehsan
Taha-Mehlitz, Stephanie
Paradiso, Viola
Srivatsa, Sumana
de Weck, Antoine
Roma, Guglielmo
Lanzafame, Manuela
Bolli, Martin
Beerenwinkel, Niko
von Flüe, Markus
Terracciano, Luigi M
Piscuoglio, Salvatore
Ng, Kiu Yan Charlotte
Department for BioMedical Research (DBMR)
Subject(s)

600 - Technology::610...

Series
Nucleic acids research
ISSN or ISBN (if monograph)
0305-1048
Publisher
Oxford University Press
Language
English
Publisher DOI
10.1093/nar/gkab627
PubMed ID
34313788
Description
Systematic perturbation screens provide comprehensive resources for the elucidation of cancer driver genes. The perturbation of many genes in relatively few cell lines in such functional screens necessitates the development of specialized computational tools with sufficient statistical power. Here we developed APSiC (Analysis of Perturbation Screens for identifying novel Cancer genes) to identify genetic drivers and effectors in perturbation screens even with few samples. Applying APSiC to the shRNA screen Project DRIVE, APSiC identified well-known and novel putative mutational and amplified cancer genes across all cancer types and in specific cancer types. Additionally, APSiC discovered tumor-promoting and tumor-suppressive effectors, respectively, for individual cancer types, including genes involved in cell cycle control, Wnt/β-catenin and hippo signalling pathways. We functionally demonstrated that LRRC4B, a putative novel tumor-suppressive effector, suppresses proliferation by delaying cell cycle and modulates apoptosis in breast cancer. We demonstrate APSiC is a robust statistical framework for discovery of novel cancer genes through analysis of large-scale perturbation screens. The analysis of DRIVE using APSiC is provided as a web portal and represents a valuable resource for the discovery of novel cancer genes.
Handle
https://boris-portal.unibe.ch/handle/20.500.12422/59211
Show full item
File(s)
FileFile TypeFormatSizeLicensePublisher/Copright statementContent
gkab627.pdftextAdobe PDF6.19 MBpublishedOpen
BORIS Portal
Bern Open Repository and Information System
Build: d1c7f7 [27.06. 13:56]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo